SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland.
Saved in:
| Title: | SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland. |
|---|---|
| Authors: | Olafsson, Sigurdur (AUTHOR), Löve, Thorvardur J. (AUTHOR), Fridriksdottir, Ragnheidur H. (AUTHOR), Tyrfingsson, Thorarinn (AUTHOR), Runarsdottir, Valgerdur (AUTHOR), Hansdottir, Ingunn (AUTHOR), Bergmann, Ottar M. (AUTHOR), Björnsson, Einar S. (AUTHOR), Johannsson, Birgir (AUTHOR), Sigurdardottir, Bryndis (AUTHOR), Löve, Arthur (AUTHOR), Baldvinsdóttir, Guðrún Erna (AUTHOR), Sigmundsdottir, Gudrun (AUTHOR), Hernandez, Ubaldo Benitez (AUTHOR), Heimisdottir, Maria (AUTHOR), Gottfredsson, Magnús (AUTHOR) |
| Source: | Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS827-S827. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
